ARCHIVES

NCI To Study Whether It Gets The Most From Advisors.

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Commit $32 Mil. To Chemoprevention

June 7, 1991

ACCC Comments On DRGs to Be Review By PROPAC

September 6, 1985

NCI Advisory Group, Other Cancer Meetings

November 26, 1976

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

Additional DCE Contract Concepts

November 16, 1984

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012